Immunobiology of HER-2/neuoncoprotein and its potential application in cancer immunotherapy
β Scribed by ConstantinN. Baxevanis; PanagiotaA. Sotiropoulou; NectariaN. Sotiriadou; Michael Papamichail
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 235 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Archival surgical specimens from I ,2 I0 female breast cancer patients treated between 1968 and 1971 and with a 19year follow-up were reanalyzed with special reference to several parameters, such as size of the primary tumor, axillary nodal involvement, histologic grade, degree of inflammatory infil
## Abstract Human cathelicidin LLβ37, a host defense peptide derived from leukocytes and epithelial cells, plays a crucial role in innate and adaptive immunity. Not only does LLβ37 eliminate pathogenic microbes directly but also modulates host immune responses. Emerging evidence from tumor biology
The total cellular p185 HER-2/neu protein (p185) content was measured by ELISA in 346 invasive primary breast cancers, and the results were compared with those of estrogen (ER) and progesterone (PR) receptors, pS2 and Cathepsin D (Cat D) content. At a cut-off level of 260 fmol/mg protein, 53 of the